?? On International Day of Women and Girls in Science, we celebrate the incredible contributions of women and girls who are driving innovation, discovery, and progress in STEM fields. At T2 Biosystems, we are proud to support and work alongside the brilliant women advancing science and transforming healthcare every day. Let’s inspire the next generation of women scientists to lead the way toward a brighter, healthier future! ?????? #WomenInScience #InternationalDayOfWomenInScience #STEMInnovation
关于我们
T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR?, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers.
- 网站
-
https://www.t2biosystems.com
T2 Biosystems的外部链接
- 所属行业
- 生物技术
- 规模
- 51-200 人
- 总部
- Lexington，MA
- 类型
- 上市公司
- 创立
- 2006
- 领域
- Sepsis、Hemostasis、Infectious Diseases、Candidemia和In-vitro diagnostics
地点
T2 Biosystems员工
动态
-
This week, we honor the strength and resilience of sepsis survivors while raising awareness about the challenges they face. At T2 Biosystems, we are committed to advancing rapid diagnostics to enable early detection and targeted treatment, helping save lives and improve outcomes. To all sepsis survivors, you inspire us to continue innovating for a healthier future. ???? #SepsisSurvivorsWeek #SepsisAwareness #HealthcareInnovation
-
-
??? Today, on World Cancer Day, we stand united in the fight against cancer. At T2 Biosystems, we recognize the critical role of early detection and innovative diagnostics in detecting life-threatening infections in immunocompromised patients, including those undergoing cancer treatments. #WorldCancerDay #EarlyDetection #InnovationInDiagnostics
-
-
We're excited to share a new case study highlighting how our T2Bacteria Panel played a crucial role in diagnosing culture-negative infective endocarditis. ?? Read the full case study here: https://ow.ly/UkPz50UyQit #Innovation #Endocarditis #Diagnostics #Healthcare #T2Bacteria
-
-
Milestone Alert! ?? T2 Biosystems has surpassed 250,000 shipped #sepsis tests, highlighting the growing adoption of our innovative direct-from-blood diagnostic technology! ?? We’re honored to support clinicians in delivering faster, targeted therapy for patients with bloodstream infections and sepsis. Together, we’re advancing the fight against sepsis. ?? Read more: https://ow.ly/68EX50UtA7q
-
?? Missed the live webinar? "The Reason for Resonance: Using T2MR to Advance the Diagnosis of Bloodstream Infections" is now available on-demand! ?? Watch now: https://ow.ly/SZQl50UsJ6y #Labroots #SepsisAwareness #RapidDiagnostics #HealthcareInnovation
-
-
T2 Biosystems announces plans to license our proprietary technology to expand access to direct-from-whole-blood diagnostic capabilities. This initiative opens doors for innovations in medical diagnostics, potentially bringing life-saving advancements to more hospitals and patients worldwide. Learn more: https://ow.ly/S8mp50UnECP #Innovation #HealthcareTechnology #Diagnostics
-
-
Join us for "Reason and Resonance: Using T2MR to Advance the Diagnosis of Bloodstream Infections" and discover how innovative T2 Magnetic Resonance technology is transforming sepsis care. Learn about its impact on early diagnosis and targeted therapy for bloodstream infections. ?? Date: December 3, 2024 ?? Register now: https://ow.ly/pl3Y50Uje7F #SepsisAwareness #RapidDiagnostics #HealthcareInnovation #Labroots
-
-
?? December 1 is World AIDS Day—a time to raise awareness and support for those living with HIV/AIDS. People with HIV/AIDS face a higher risk of infections, including sepsis, due to weakened immune systems. Early detection and targeted treatment are critical to improving outcomes. At T2 Biosystems, we’re committed to advancing diagnostics that can make a difference for vulnerable populations. Together, we can fight for better care and a healthier future. ?? #WorldAIDSDay #SepsisAwareness #HealthcareInnovation #T2Biosystems
-
-
Don’t miss our December 3rd webinar, where Dr. Sne?ana Jovanovi? will share her experience with T2 Biosystems sepsis diagnostics. Through case studies, participants will examine the role of early diagnosis of bloodstream infections, comparing the routine microbiology workflow with T2 Magnetic Resonance (T2MR) Technology. This session aims to provide a practical understanding of how these tools can support clinical decision-making and improve patient outcomes. Register today! T2 Biosystems